These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38677580)

  • 21. Alterations in Taenia crassiceps cysticerci cytoskeleton induced by nitazoxanide and flubendazole.
    de Lima NF; Picanço GA; Valencia DGR; Villegas EOL; Mellado MDRE; Ambrosio JR; Vinaud MC
    Acta Trop; 2021 Sep; 221():106027. PubMed ID: 34216560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts.
    Palomares-Alonso F; Piliado JC; Palencia G; Ortiz-Plata A; Jung-Cook H
    J Antimicrob Chemother; 2007 Feb; 59(2):212-8. PubMed ID: 17114175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocysticercosis: a review.
    Del Brutto OH
    ScientificWorldJournal; 2012; 2012():159821. PubMed ID: 22312322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological changes to early stage Taenia solium cysticerci following oxfendazole treatment.
    Liu YJ; Li QZ; Hao YH
    Vet J; 2003 Jan; 165(1):73-7. PubMed ID: 12618073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitazoxanide induces in vitro metabolic acidosis in Taenia crassiceps cysticerci.
    Isac E; de A Picanço G; da Costa TL; de Lima NF; de S M M Alves D; Fraga CM; de S Lino Junior R; Vinaud MC
    Exp Parasitol; 2016 Dec; 171():17-22. PubMed ID: 27751770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps.
    Mahanty S; Madrid EM; Nash TE
    Antimicrob Agents Chemother; 2013 Feb; 57(2):990-5. PubMed ID: 23229489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocysticercosis.
    Del Brutto OH
    Handb Clin Neurol; 2014; 121():1445-59. PubMed ID: 24365429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of the blood-brain barrier in pigs naturally infected with Taenia solium, untreated and after anthelmintic treatment.
    Guerra-Giraldez C; Marzal M; Cangalaya C; Balboa D; Orrego MÁ; Paredes A; Gonzales-Gustavson E; Arroyo G; García HH; González AE; Mahanty S; Nash TE;
    Exp Parasitol; 2013 Aug; 134(4):443-6. PubMed ID: 23684909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.
    Gavidia CM; Gonzalez AE; Barron EA; Ninaquispe B; Llamosas M; Verastegui MR; Robinson C; Gilman RH
    PLoS Negl Trop Dis; 2010 Feb; 4(2):e616. PubMed ID: 20186332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural History of Treated Subarachnoid Neurocysticercosis.
    Nash TE; O'Connell EM; Hammoud DA; Wetzler L; Ware JM; Mahanty S
    Am J Trop Med Hyg; 2020 Jan; 102(1):78-89. PubMed ID: 31642423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocysticercosis: Diagnostic problems & current therapeutic strategies.
    Rajshekhar V
    Indian J Med Res; 2016 Sep; 144(3):319-326. PubMed ID: 28139530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model.
    Gonzalez AE; Bustos JA; Jimenez JA; Rodriguez ML; Ramirez MG; Gilman RH; Garcia HH;
    Am J Trop Med Hyg; 2012 Aug; 87(2):292-6. PubMed ID: 22855760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cysticidal Therapy for Diffuse Parenchymal and Calcific Neurocysticercosis.
    Agarwal A; Srivastava MVP; Gupta A; Rajan R; Garg A; Mishra B; Singh MB; Bhatia R; Vishnu VY
    Am J Trop Med Hyg; 2020 Nov; 104(2):734-738. PubMed ID: 33236706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
    Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E
    Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticosteroid use in neurocysticercosis.
    Nash TE; Mahanty S; Garcia HH;
    Expert Rev Neurother; 2011 Aug; 11(8):1175-83. PubMed ID: 21797658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental encephalitis caused by Taenia crassiceps cysticerci in mice.
    Matos-Silva H; Reciputti BP; Paula EC; Oliveira AL; Moura VB; Vinaud MC; Oliveira MA; Lino-Júnior Rde S
    Arq Neuropsiquiatr; 2012 Apr; 70(4):287-92. PubMed ID: 22358311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocysticercosis in the infant of a pregnant mother with a tapeworm.
    Asnis D; Kazakov J; Toronjadze T; Bern C; Garcia HH; McAuliffe I; Bishop H; Lee L; Grossmann R; Garcia MA; Di John D
    Am J Trop Med Hyg; 2009 Sep; 81(3):449-51. PubMed ID: 19706913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response to Taenia solium cysticerci after anti-parasitic therapy.
    Singh AK; Singh SK; Singh A; Gupta KK; Khatoon J; Prasad A; Rai RP; Gupta RK; Tripathi M; Husain N; Prasad KN
    Int J Parasitol; 2015 Oct; 45(12):749-59. PubMed ID: 26336013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
    Garcia HH; Del Brutto OH;
    Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep.
    Gavidia CM; Gonzalez AE; Lopera L; Jayashi C; Angelats R; Barron EA; Ninaquispe B; Villarreal L; Garcia HH; Verastegui MR; Gilman RH
    Am J Trop Med Hyg; 2009 Mar; 80(3):367-72. PubMed ID: 19270283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.